Overview and Scope
Virology testing refers to diagnosing viral infections by detecting the presence of viruses or specific viral components in biological samples, such as blood, saliva, or tissue. These tests are used in identifying, monitoring, and controlling viral diseases.
Sizing and Forecast
The virology testing market size has grown strongly in recent years. It will grow from $5.05 billion in 2023 to $5.53 billion in 2024 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to emergence of new and complex viruses, increase in infectious disease outbreaks, expansion of healthcare infrastructure, growing awareness of the importance of early virus detection, expansion of point-of-care virology testing options.
The virology testing market size is expected to see strong growth in the next few years. It will grow to $7.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to adoption of next-generation sequencing in virology, impact of climate change on the spread of vector-borne viruses, rise of mobile and at-home virology testing solutions, adoption of digital pathology in virology diagnostics, increasing use of big data analytics for virology surveillance. Major trends in the forecast period include technological advancements in molecular diagnostics, integration of artificial intelligence in virology testing, development of innovative biomarkers for virus detection, development of novel antiviral therapies and treatments, emphasis on sustainable and eco-friendly testing methods.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/virology-testing-global-market-report
Segmentation & Regional Insights
The virology testing market covered in this report is segmented –
1) By Type: Instruments, Assay Kits And Consumables
2) By Diagnostic Technique: Molecular Diagnostics Method, Immunoassay Based Method, Mass Spectroscopy Based Method, Other Techniques
3) By Application: Skin And Soft Tissue Infections, Respiratory Tract Infections, Gastrointestinal Tract Infections, Urinary Tract Infection, Eye Infections, Sexually Transmitted Diseases, Perinatal Infections
4) By End User: Hospitals, Clinics, Laboratories, Diagnostic Centers, Blood Banks, Pharmacies
North America was the largest region in the virology testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=12531&type=smp
Major Driver Impacting Market Growth
The rising incidence of viral infections is expected to propel the growth of the virology testing market going forward. Viral infections are infectious diseases caused by viruses, microscopic infectious agents composed of genetic material (DNA or RNA) surrounded by a protein coat. Virology testing is essential for accurate diagnosis, surveillance, research, and public health preparedness. It enables the identification of viral pathogens, guides treatment strategies, tracks the spread of infections, and supports the development of new interventions. The increasing demand for virology testing stems from the need to manage viral infections and mitigate their impact effectively. For instance, according to the Texas Department of State Health Services, a US-based state agency of Texas, the number of reported varicella cases in Texas increased from 354 in 2021 to 348 in 2020. Therefore, the rising incidence of viral infections is driving the growth of the virology testing market.
Key Industry Players
Major companies operating in the virology testing market report are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline PLC, Boehringer Ingelheim International GmbH, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., WuXi AppTec Co. Ltd., Hologic Inc., Sartorius AG, bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc., Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech PLC, Diamedix Corporation, Biospherix Ltd., Imquest Biosciences Inc., Novogene Co Ltd., Scienion AG, Vircell SL, Sequenom Inc.
The virology testing market report table of contents includes:
1. Executive Summary
2. Virology Testing Market Characteristics
3. Virology Testing Market Trends And Strategies
4. Virology Testing Market – Macro Economic Scenario
5. Global Virology Testing Market Size and Growth
.
.
.
31. Virology Testing Market Other Major And Innovative Companies
32. Global Virology Testing Market Competitive Benchmarking
33. Global Virology Testing Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Virology Testing Market
35. Virology Testing Market Future Outlook and Potential Analysis
36.Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
